Contract 75D30121C11023
Asrt, Inc. · Department Of Health And Human Services · September 23, 2021
Asrt, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 23, 2021 for $2.23 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Smyrna, GA. It was awarded under an 8(a) sole-source set-aside. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 9, 2024. If all options are exercised, the contract could reach $5.27 million.
Contract details
- PIID
- 75D30121C11023
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- 8(A) Sole Source
- Competition
- Not Available For Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Support- Professional: Other
- Place of performance
- Smyrna, GA
- First action
- September 23, 2021
- Latest action
- August 9, 2024
Description
SCIENTIFIC AND TECHNICAL SUPPORT FOR DSR
Modification timeline
-
August 9, 2024Mod P00003 · Exercise An Option$5.27M
-
September 23, 2021Base award$1.45M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30121C11023?
Contract 75D30121C11023 is a federal contract awarded to Asrt, Inc. by Department Of Health And Human Services on September 23, 2021 for $2.23 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75D30121C11023?
Asrt, Inc. won contract 75D30121C11023 from Department Of Health And Human Services.
How much is contract 75D30121C11023 worth?
Contract 75D30121C11023 has obligated $2.23 million to date, with a total potential value of $5.27 million if all options are exercised.